- News- Machine learning–derived risk score predicts heart failure risk in diabetes patients- September 22, 2019- Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%. 
- News- Dapagliflozin meets primary endpoint in the DAPA-HF trial- August 21, 2019- AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor. 
- News- New biomarker model outmatches conventional risk factors for predicting mortality- August 20, 2019- Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model. 
![1]() - News- FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment- July 25, 2019- It is the first glucagon therapy approved for this indication that is administrable without an injection. 
![1]() - News- FDA issues warning on insulin pump cybersecurity weakness- June 28, 2019- The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the United States are affected. 
![1]() - News- Aspirin shows little benefit for primary prevention of vascular disease in diabetes- May 15, 2019- Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events? 
![1]() - News- SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF- May 9, 2019- NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said. 
![1]() - News- Statin exposure associated with idiopathic inflammatory myositis- April 15, 2019- What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis? 
- News- Newer antihyperglycemic drugs have distinctive CV, kidney benefits- March 12, 2019- SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes. 
![1]() - News- Subclinical hypothyroidism boosts immediate risk of heart failure- January 24, 2019- CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure. 





